{"text": "rt AT_USER amazing how darzalex $jnj has pulled ahead of empliciti $bmy. here's sellside consensus change over 2 years ($m), via AT_USER"}
{"text": "rt AT_USER $bmy makes survival in melanoma combo trial. $mrk, #aacr17 URL"}
{"text": "rt AT_USER unravelling the myriad future uses of darzalex $jnj, and how it stacks up vs empliciti $bmy. via AT_USER URL"}
{"text": "rt AT_USER key presentations and posters at easl $mrk $gild $bmy $abbv URL"}
{"text": "rt AT_USER interesting deal - $biib licenses anti-tau ab from... $bmy ! $300m up front URL"}
{"text": "rt AT_USER anyone know the target of bms-986218?  a huge new phase 1 #immunotherapy trial from $bmy (531 patient!) registered! ht\u00a1\u00ad"}
{"text": "rt AT_USER key presentations and posters at easl $mrk $gild $bmy $abbv URL"}
{"text": "anyone know the target of bms-986218?  a huge new phase 1 #immunotherapy trial from $bmy (531 patient!) registered! URL"}
{"text": "rt AT_USER understanding cancer immune profiles, and implications for io therapy, was a key theme at #aacr2017 $ibb $mrk $bmy URL"}
{"text": "rt AT_USER b4 &amp; if approved? $brk $iep $ko $pep $jazz $tst $aapl $sny $prgo $bmy $gild $hlf $amgn $acad $blue $exel $jnj $teva URL"}
{"text": "b4 &amp; if approved? $brk $iep $ko $pep $jazz $tst $aapl $sny $prgo $bmy $gild $hlf $amgn $acad $blue $exel $jnj $teva URL"}
{"text": "industry allocations &amp; compounding returns $bmy $jnj $ko $mcd $mo $mrk $pep $pfe $sphd $spy $xlb\u00a1\u00ad\u00a1\u00ad URL"}
{"text": "industry allocations &amp; compounding returns URL $bmy $jnj $ko $mcd $mo $mrk $pep $pfe $sphd $spy $xlb $xle $xlf $xlk"}
{"text": "industry allocations &amp; compounding returns URL $bmy $jnj $ko $mcd $mo $mrk $pep $pfe $sphd $spy $xlb $xle $xlf $xlk"}
{"text": "industry allocations &amp; compounding returns URL $bmy $jnj $ko $mcd $mo $mrk $pep $pfe $sphd $spy $xlb $xle $xlf $xlk"}
{"text": "rt AT_USER understanding cancer immune profiles, and implications for io therapy, was a key theme at #aacr2017 $ibb $mrk $bmy URL"}
{"text": "AT_USER $bmy catalysts URL"}
{"text": "key presentations and posters at easl $mrk $gild $bmy $abbv URL"}
{"text": "rt AT_USER #biotech roundup: crispr appeal, bristol deals, stock pumping &amp; more URL $bmy $omed $gern $nbix"}
{"text": "rt AT_USER $bmy sells anti-tau drug acquired thru iperian to $biib for $300m upfront and $410m in milestones"}
{"text": "rt AT_USER in a separate deal, $bmy selling dmd drug to roche for $170m upfront + $205m in milestones"}
{"text": "rt AT_USER biogen is building up its alzheimer's drug arsenal with a new licensing deal $biib $bmy URL via AT_USER"}
{"text": "rt AT_USER $biib, $rhhby ink deals with $bmy for rare disease drugs URL"}
{"text": "bristol-myers squibb co $bmy stake held by auxier asset management URL #stocks"}
{"text": "bristol-myers squibb co $bmy stake held by auxier asset management URL"}
{"text": "bristol-myers squibb co $bmy stake held by auxier asset management URL"}
{"text": "rt AT_USER a peek into the markets: stock futures mostly lower ahead of initial jobless claims URL $apog $biib $bmy\u00a1\u00ad"}
{"text": "#bristolmyerssquibb bristol-myers squibb receives daily news sentiment rating of 0.15. read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristol-myers squibb receives daily news sentiment rating of 0.15. read more: URL $bmy"}
{"text": "rt AT_USER #identify #new #growth #opportunities at URL #research and #analysis $gmcr $slb $teva $bmy #ces2018 #\u00a1\u00ad"}
{"text": "#identify #new #growth #opportunities at URL #research and #analysis $gmcr $slb $teva $bmy #ces2018 #ai"}
{"text": "rt AT_USER more big #pharma out-licensing, from $bmy, peer-to-peer dealmaking URL"}
{"text": "rt AT_USER #create #value with #imagination and #creativity at your company - #dontstop URL $teva $bmy #fridayfe\u00a1\u00ad"}
{"text": "rt AT_USER #create #value with #imagination and #creativity at your company - #dontstop URL $teva $bmy #fridayfe\u00a1\u00ad"}
{"text": "#create #value with #imagination and #creativity at your company - #dontstop URL $teva $bmy #fridayfeeling"}
